Cargando…

Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging

OBJECTIVES: The 8th International Forum for Liver Magnetic Resonance Imaging (MRI), held in Basel, Switzerland, in October 2017, brought together clinical and academic radiologists from around the world to discuss developments in and reach consensus on key issues in the field of gadoxetic acid–enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zech, Christoph J., Ba-Ssalamah, Ahmed, Berg, Thomas, Chandarana, Hersh, Chau, Gar-Yang, Grazioli, Luigi, Kim, Myeong-Jin, Lee, Jeong Min, Merkle, Elmar M., Murakami, Takamichi, Ricke, Jens, B. Sirlin, Claude, Song, Bin, Taouli, Bachir, Yoshimitsu, Kengo, Koh, Dow-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890618/
https://www.ncbi.nlm.nih.gov/pubmed/31385048
http://dx.doi.org/10.1007/s00330-019-06369-4
_version_ 1783475644694265856
author Zech, Christoph J.
Ba-Ssalamah, Ahmed
Berg, Thomas
Chandarana, Hersh
Chau, Gar-Yang
Grazioli, Luigi
Kim, Myeong-Jin
Lee, Jeong Min
Merkle, Elmar M.
Murakami, Takamichi
Ricke, Jens
B. Sirlin, Claude
Song, Bin
Taouli, Bachir
Yoshimitsu, Kengo
Koh, Dow-Mu
author_facet Zech, Christoph J.
Ba-Ssalamah, Ahmed
Berg, Thomas
Chandarana, Hersh
Chau, Gar-Yang
Grazioli, Luigi
Kim, Myeong-Jin
Lee, Jeong Min
Merkle, Elmar M.
Murakami, Takamichi
Ricke, Jens
B. Sirlin, Claude
Song, Bin
Taouli, Bachir
Yoshimitsu, Kengo
Koh, Dow-Mu
author_sort Zech, Christoph J.
collection PubMed
description OBJECTIVES: The 8th International Forum for Liver Magnetic Resonance Imaging (MRI), held in Basel, Switzerland, in October 2017, brought together clinical and academic radiologists from around the world to discuss developments in and reach consensus on key issues in the field of gadoxetic acid–enhanced liver MRI since the previous Forum held in 2013. METHODS: Two main themes in liver MRI were considered in detail at the Forum: the use of gadoxetic acid for contrast-enhanced MRI in patients with liver cirrhosis and the technical performance of gadoxetic acid–enhanced liver MRI, both opportunities and challenges. This article summarises the expert presentations and the delegate voting on consensus statements discussed at the Forum. RESULTS AND CONCLUSIONS: It was concluded that gadoxetic acid–enhanced MRI has higher sensitivity for the diagnosis of hepatocellular carcinoma (HCC), when compared with multidetector CT, by utilising features of hyperenhancement in the arterial phase and hypointensity in the hepatobiliary phase (HBP). Recent HCC management guidelines recognise an increasing role for gadoxetic acid–enhanced MRI in early diagnosis and monitoring post-resection. Additional research is needed to define the role of HBP in predicting microvascular invasion, to better define washout during the transitional phase in gadoxetic acid–enhanced MRI for HCC diagnosis, and to reduce the artefacts encountered in the arterial phase. Technical developments are being directed to shortening the MRI protocol for reducing time and patient discomfort and toward utilising faster imaging and non-Cartesian free-breathing approaches that have the potential to improve multiphasic dynamic imaging. KEY POINTS: • Gadoxetic acid–enhanced MRI provides higher diagnostic sensitivity than CT for diagnosing HCC. • Gadoxetic acid–enhanced MRI has roles in early-HCC diagnosis and monitoring post-resection response. • Faster imaging and free-breathing approaches have potential to improve multiphasic dynamic imaging. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06369-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6890618
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-68906182019-12-26 Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging Zech, Christoph J. Ba-Ssalamah, Ahmed Berg, Thomas Chandarana, Hersh Chau, Gar-Yang Grazioli, Luigi Kim, Myeong-Jin Lee, Jeong Min Merkle, Elmar M. Murakami, Takamichi Ricke, Jens B. Sirlin, Claude Song, Bin Taouli, Bachir Yoshimitsu, Kengo Koh, Dow-Mu Eur Radiol Magnetic Resonance OBJECTIVES: The 8th International Forum for Liver Magnetic Resonance Imaging (MRI), held in Basel, Switzerland, in October 2017, brought together clinical and academic radiologists from around the world to discuss developments in and reach consensus on key issues in the field of gadoxetic acid–enhanced liver MRI since the previous Forum held in 2013. METHODS: Two main themes in liver MRI were considered in detail at the Forum: the use of gadoxetic acid for contrast-enhanced MRI in patients with liver cirrhosis and the technical performance of gadoxetic acid–enhanced liver MRI, both opportunities and challenges. This article summarises the expert presentations and the delegate voting on consensus statements discussed at the Forum. RESULTS AND CONCLUSIONS: It was concluded that gadoxetic acid–enhanced MRI has higher sensitivity for the diagnosis of hepatocellular carcinoma (HCC), when compared with multidetector CT, by utilising features of hyperenhancement in the arterial phase and hypointensity in the hepatobiliary phase (HBP). Recent HCC management guidelines recognise an increasing role for gadoxetic acid–enhanced MRI in early diagnosis and monitoring post-resection. Additional research is needed to define the role of HBP in predicting microvascular invasion, to better define washout during the transitional phase in gadoxetic acid–enhanced MRI for HCC diagnosis, and to reduce the artefacts encountered in the arterial phase. Technical developments are being directed to shortening the MRI protocol for reducing time and patient discomfort and toward utilising faster imaging and non-Cartesian free-breathing approaches that have the potential to improve multiphasic dynamic imaging. KEY POINTS: • Gadoxetic acid–enhanced MRI provides higher diagnostic sensitivity than CT for diagnosing HCC. • Gadoxetic acid–enhanced MRI has roles in early-HCC diagnosis and monitoring post-resection response. • Faster imaging and free-breathing approaches have potential to improve multiphasic dynamic imaging. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00330-019-06369-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-08-05 2020 /pmc/articles/PMC6890618/ /pubmed/31385048 http://dx.doi.org/10.1007/s00330-019-06369-4 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Magnetic Resonance
Zech, Christoph J.
Ba-Ssalamah, Ahmed
Berg, Thomas
Chandarana, Hersh
Chau, Gar-Yang
Grazioli, Luigi
Kim, Myeong-Jin
Lee, Jeong Min
Merkle, Elmar M.
Murakami, Takamichi
Ricke, Jens
B. Sirlin, Claude
Song, Bin
Taouli, Bachir
Yoshimitsu, Kengo
Koh, Dow-Mu
Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
title Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
title_full Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
title_fullStr Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
title_full_unstemmed Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
title_short Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging
title_sort consensus report from the 8th international forum for liver magnetic resonance imaging
topic Magnetic Resonance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890618/
https://www.ncbi.nlm.nih.gov/pubmed/31385048
http://dx.doi.org/10.1007/s00330-019-06369-4
work_keys_str_mv AT zechchristophj consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT bassalamahahmed consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT bergthomas consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT chandaranahersh consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT chaugaryang consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT grazioliluigi consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT kimmyeongjin consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT leejeongmin consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT merkleelmarm consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT murakamitakamichi consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT rickejens consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT bsirlinclaude consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT songbin consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT taoulibachir consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT yoshimitsukengo consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging
AT kohdowmu consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging